Compare Merck & Co., Inc. (MRK) vs United Parcel Service Inc (UPS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Merck & Co., Inc. vs United Parcel Service Inc — how do they compare? Merck & Co., Inc. trades at $142.38 (market cap $352.29B), while United Parcel Service Inc trades at $94.21 (market cap $78.52B). The key difference: Merck & Co., Inc. is far larger — about 4.5× United Parcel Service Inc's market cap, and United Parcel Service Inc pays the higher dividend (7.11%). Which is the better fit depends on your goals — on Pluang, investors hold Merck & Co., Inc. for 98 Days and United Parcel Service Inc for 141 Days on average.
| MRK | UPS | |
|---|---|---|
Market Cap | $352.29B | $78.52B |
Volume | 6,348,796 | 5,159,366 |
Sector | Health | Industrials |
52-Week High | $156.43 | $120.00 |
52-Week Low | $82.49 | $82.87 |
Typical Hold Time | 98 Days | 141 Days |
Enterprise Value | $399.05B | $102.54B |
Dividend Yield | 2.38% | 7.11% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Merck (MRK) trades at $142.40, up 0.33% on the day, with a bearish technical signal but strong analyst support. The company reported revenue of $65.0B in 2025 with a net income margin of 28.07%, though 2026 projections show a sharp decline to 4.76%. Recent acquisition activity includes the tender offer for Terns Pharmaceuticals to bolster its oncology pipeline, while cash flow trends indicate significant investing outflows in 2026.
The outlook is mixed: robust fundamentals and a consensus price target of $159.59 suggest upside, but high valuation ratios (P/E 114.23) and projected earnings volatility pose risks. Investors should weigh strong institutional buying against technical weakness and competitive pressures in the pharma sector.
UPS trades at $94.11, up 1.07% with bearish technical signals but strong fundamentals including a 17.15 P/E ratio and 29.66% ROE. The company has beaten earnings estimates for three consecutive quarters, though revenue has declined from $100.3B in 2022 to $88.7B in 2025. Recent developments include the UPS Secure Commerce platform launch and TikTok Shop partnership, while analysts maintain a $118.67 consensus price target despite near-term margin pressures.
UPS presents a value opportunity with attractive valuation metrics and consistent earnings beats, though declining revenue and competitive pressures from Amazon pose challenges. The 7% dividend yield provides income support, but investors should monitor domestic package volume trends and margin sustainability given recent analyst downgrades and bearish technical indicators.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →About United Parcel Service Inc
United Parcel Service, Inc. (UPS) delivers packages and documents throughout the United States and in other countries and territories. The Company also provides global supply chain services and less-than-truckload transportation, primarily in the US UPS's business consists of integrated air and ground pick-up and delivery network
Read more on UPS →
